These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

841 related articles for article (PubMed ID: 16431187)

  • 21. Aminoterminal brain-type natriuretic peptide levels correlate with heart failure in patients with bidirectional Glenn anastomosis and with morbidity after the Fontan operation.
    Lechner E; Schreier-Lechner EM; Hofer A; Gitter R; Mair R; Biebl A; Tulzer G
    J Thorac Cardiovasc Surg; 2009 Sep; 138(3):560-4. PubMed ID: 19698835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The additive value of N-terminal pro-B-type natriuretic peptide testing at the emergency department in patients with acute dyspnoea.
    van der Burg-de Graauw N; Cobbaert CM; Middelhoff CJ; Bantje TA; van Guldener C
    Eur J Intern Med; 2009 May; 20(3):301-6. PubMed ID: 19393498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Usefulness of NTproBNP in the emergency management of patients with severe dyspnea and an uncertain heart failure diagnosis].
    Pascual Figal DA; Cerdán Sánchez MC; Noguera Velasco JA; Casas Pina T; Muñoz Gimeno L; García Rodríguez R; Ruipérez Abizanda JA; Martínez Hernández P; Valdés Chávarri M
    Rev Esp Cardiol; 2005 Oct; 58(10):1155-61. PubMed ID: 16238983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic performance and cost effectiveness of measurements of plasma N-terminal pro brain natriuretic peptide in patients presenting with acute dyspnea or peripheral edema.
    Behnes M; Brueckmann M; Ahmad-Nejad P; Lang S; Wolpert C; Elmas E; Kaelsch T; Gruettner J; Weiss C; Borggrefe M; Neumaier M
    Int J Cardiol; 2009 Jun; 135(2):165-74. PubMed ID: 18603317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short-term mortality risk in emergency department acute heart failure.
    Peacock WF; Nowak R; Christenson R; DiSomma S; Neath SX; Hartmann O; Mueller C; Ponikowski P; Möckel M; Hogan C; Wu AH; Richards M; Filippatos GS; Anand I; Ng LL; Daniels LB; Morgenthaler N; Anker SD; Maisel AS
    Acad Emerg Med; 2011 Sep; 18(9):947-58. PubMed ID: 21906204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amino-terminal pro-B-type natriuretic peptide testing for the diagnosis or exclusion of heart failure in patients with acute symptoms.
    Januzzi JL; Chen-Tournoux AA; Moe G
    Am J Cardiol; 2008 Feb; 101(3A):29-38. PubMed ID: 18243855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Usefulness of B-type natriuretic peptide (BNP) for the diagnosis of new-onset heart failure with a preserved left ventricular systolic function in longstanding hypertensive patients with acute dyspnea].
    Arquès S; Roux E; Sbragia P; Pieri B; Gélisse R; Luccioni R; Ambrosi P
    Arch Mal Coeur Vaiss; 2007 Feb; 100(2):113-20. PubMed ID: 17474496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
    Neuhold S; Huelsmann M; Strunk G; Stoiser B; Struck J; Morgenthaler NG; Bergmann A; Moertl D; Berger R; Pacher R
    J Am Coll Cardiol; 2008 Jul; 52(4):266-72. PubMed ID: 18634981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-terminal pro-brain natriuretic peptide testing in the emergency department: beneficial effects on hospitalization, costs, and outcome.
    Rutten JH; Steyerberg EW; Boomsma F; van Saase JL; Deckers JW; Hoogsteden HC; Lindemans J; van den Meiracker AH
    Am Heart J; 2008 Jul; 156(1):71-7. PubMed ID: 18585499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic and prognostic usefulness of natriuretic peptides in emergency department patients with dyspnea.
    Collins SP; Ronan-Bentle S; Storrow AB
    Ann Emerg Med; 2003 Apr; 41(4):532-45. PubMed ID: 12658254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure.
    Rudiger A; Gasser S; Fischler M; Hornemann T; von Eckardstein A; Maggiorini M
    Crit Care Med; 2006 Aug; 34(8):2140-4. PubMed ID: 16763507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utility of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) to distinguish between congestive heart failure and non-cardiac causes of acute dyspnea in cats.
    Fox PR; Oyama MA; Reynolds C; Rush JE; DeFrancesco TC; Keene BW; Atkins CE; Macdonald KA; Schober KE; Bonagura JD; Stepien RL; Kellihan HB; Nguyenba TP; Lehmkuhl LB; Lefbom BK; Moise NS; Hogan DF
    J Vet Cardiol; 2009 May; 11 Suppl 1():S51-61. PubMed ID: 19394287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential diagnosis of acute dyspnea: the value of B natriuretic peptides in the emergency department.
    Ray P; Delerme S; Jourdain P; Chenevier-Gobeaux C
    QJM; 2008 Nov; 101(11):831-43. PubMed ID: 18664534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical value of rapid assay for plasma B-type natriuretic peptide in differentiating congestive heart failure from pulmonary causes of dyspnoea.
    Zhao SQ; Hu YM; Li Q; Liu XR; Wang M; Zhang WY; Wu T; Nie XL; Zhao N; Wang LR
    Int J Clin Pract; 2008 Feb; 62(2):214-20. PubMed ID: 18081799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic and prognostic value of uric acid in patients with acute dyspnea.
    Reichlin T; Potocki M; Breidthardt T; Noveanu M; Hartwiger S; Burri E; Klima T; Stelzig C; Laule K; Mebazaa A; Christ M; Mueller C
    Am J Med; 2009 Nov; 122(11):1054.e7-1054.e14. PubMed ID: 19854335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B-type natriuretic peptide measurements in diagnosing congestive heart failure in the dyspneic emergency department patient.
    Maisel A
    Rev Cardiovasc Med; 2002; 3 Suppl 4():S10-7. PubMed ID: 12439426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B-type natriuretic peptide for diagnosis of heart failure in emergency department patients: a critical appraisal.
    Schwam E
    Acad Emerg Med; 2004 Jun; 11(6):686-91. PubMed ID: 15175210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
    Waldo SW; Beede J; Isakson S; Villard-Saussine S; Fareh J; Clopton P; Fitzgerald RL; Maisel AS
    J Am Coll Cardiol; 2008 May; 51(19):1874-82. PubMed ID: 18466803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Obesity and suppressed B-type natriuretic peptide levels in heart failure.
    Mehra MR; Uber PA; Park MH; Scott RL; Ventura HO; Harris BC; Frohlich ED
    J Am Coll Cardiol; 2004 May; 43(9):1590-5. PubMed ID: 15120816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.